Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-20

Clinical Trial Update: A Study to Learn How Different Amounts of the Study Medicine Danuglipron Are Taken up Into the Blood in Otherwise Healthy Adults With Overweight or Obesity [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study to determine how different doses of Danuglipron are absorbed into the bloodstream in otherwise healthy adults with overweight or o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Danuglipron (danuglipron)

Snippet

Sponsor: Pfizer | Conditions: Obesity | Phase 1 | Status: COMPLETED